Admission Date:  [**2136-7-16**]              Discharge Date:   [**2136-7-30**]  Date of Birth:  [**2066-3-12**]             Sex:   M  Service: SURGERY  Allergies: No Known Allergies / Adverse Drug Reactions  Attending:[**First Name3 (LF) 473**] Chief Complaint: peri-hepatic fluid collection  Major Surgical or Invasive Procedure: [**2136-7-17**] - CT-guided drainage of a gallbladder fossa collection with percutaneous drain placement.
History of Present Illness: This is a 70-year old male with history of unresectable pancreatic cancer s/p ex-lap, open cholecystectomy and retroperitoneal lymph node biopsies on [**2136-6-28**], discharged on [**7-9**] with a post-op course complicated by gram negative bacteremia and delirium.
Past Medical History: PMH: COPD, on home oxygen 2L continuously; Anxiety; Depression; OSA; Hx of ARF; DMII, HTN, CAD s/p PTCA [**35**] yrs BU, ?seizures vs. syncope  PSH: open appendectomy, tonsillectomy, bilateral carotid stents   Social History: Patient retired (used to work for oxygen device company) and lives with his mother in [**Name (NI) 7740**].
[**2136-7-17**] CT GUIDED NEEDLE PLACTMENT - Technically successful CT-guided aspiration drainage of a gallbladder fossa collection.
Brief Hospital Course: NEURO/PAIN: The patient was maintained on IV pain medication on admission and transitioned to PO narcotic medication with adequate pain control on HOD#X once oral intake was tolerated.
The patient remained neurologically intact and without change from baseline during their stay.
His home dosing of benzodiazepines was continued without evidence of delirium or mental status change.
The patient was maintained on IV anti-hypertensive medication, with transition to their oral home anti-hypertensives on HOD#[**3-15**].
The patient's home anti-hypertensive medications were resumed on HOD#3.
He required amiodarone boluses and synchronized cardioversion to revert to sinus rhythm.
Patient treated with esmolol drip overnight and remained in sinus rhythm throughout.
Esmolol drip stopped and patient placed back on home metoprolol.
He was transfered out of the ICU and did well on oral metoprolol up to discharge without any hemodynamic instability.
GASTROINTESTINAL: The patient was NPO on admission and on HOD#2 experienced significant abdominal distention and episodic emesis requiring nasogastric tube placement.
He did receive 2-days of supplemental TPN, but this was discontinued and the patient was again allowed to maintain a regular diet, as tolerated.
He underwent CT-guided aspiration and drainage of a gallbladder fossa collection on HOD#2 with placement of an 8-French [**Last Name (un) 2823**] catheter, and 30 cc of purulent material were aspirated to bag and gravity.
The culture returned mixed bacterial flora and he was started on Vancomycin and Zosyn IV on admission.
He was continued on these antibiotics until PO intake was established, at which time the patient was transitioned to oral Augmentin.
IV antibiotics were resumed when his ICU transfer was instated, and a 10-day course was completed.
The drainage catheter was removed prior to discharge.
He was discharged with heme/oncology and palliative care follow-up regarding possible chemotherapy and hospice services.
A Foley catheter was placed on admission to monitor urine output and was removed on HOD#2, at which time the patient was able to successfully void without issue.
ID: The patient was admitted with a WBC of 26.0 which trended down following drainage and IV antibiotic treatment.
He underwent CT-guided aspiration and drainage of a gallbladder fossa collection on HOD#2 with placement of an 8-French [**Last Name (un) 2823**] catheter, and 30 cc of purulent material were aspirated to bag and gravity.
The culture returned mixed bacterial flora and he was started on Vancomycin and Zosyn IV on admission.
He was continued on these antibiotics until PO intake was established, at which time the patient was transitioned to oral Augmentin.
However, he was restarted on IV antibiotics when transfered to the ICU and these were completed during his hospitalization.
The drainage catheter was kept in place on discharge.
Blood glucose levels greater than 120 mg/dL were addressed with an insulin sliding scale.
PROPHYLAXIS: The patient was maintained on heparin 5000 units SQ TID for DVT/PE prophylaxis and encouraged to ambulate immediately once cleared by physical therapy.
GI prophylaxis was sustained with Protonix/Famotidine when necessary.
He will have VNA nursing services and PT support as a bridge to hospice care.
Medications on Admission: albuterol 5 mg/mL neb prn, alprazolam 1 mg'''', plavix 75 mg', effexor 75 mg' QOD, finasteride 5 mg', fluticasone-salmeterol 250/50 mcg', glipizide 2.5 mg'', ipatroprium-albuterol 18/103 mcg'', lisinopril 10 mg', metoprolol 100 mg', percocet 5/325 mg QID prn, promethazine 6.25 mg/5 mL' 0.5 (One half) teaspoon daily, aspirin 325 mg', docusate 100 mg', flaxseed oil, magnesium oxide 400 mg'', omega-3 FAs 1000 mg'', Lidocaine 5 % Topical Cream as needed   Discharge Medications: 1. fluticasone-salmeterol 250-50 mcg/dose Disk with Device Sig: One (1) Disk with Device Inhalation DAILY (Daily).
2. lisinopril 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
3. aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
4. calcium carbonate 200 mg calcium (500 mg) Tablet, Chewable Sig: One (1) Tablet, Chewable PO QID (4 times a day) as needed for heartburn.
5. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
6. tamsulosin 0.4 mg Capsule, Ext Release 24 hr Sig: One (1) Capsule, Ext Release 24 hr PO HS (at bedtime).
7. glipizide 5 mg Tablet Sig: 0.5 Tablet PO BID (2 times a day).
8. venlafaxine 37.5 mg Tablet Sig: One (1) Tablet PO QOD ().
9. morphine 10 mg/5 mL Solution Sig: [**6-19**] mL PO Q4H (every 4 hours).
)(s)* Refills:*2* 11. metoprolol succinate 100 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO once a day.
12. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Disp:*60 Capsule(s)* Refills:*2* 13. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Disp:*60 Tablet(s)* Refills:*2* 14. lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
15. lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 hours) as needed for anxiety, agitation, signs of withdrawal.
Discharge Instructions: You were admitted to Dr.[**Name (NI) 9886**] surgical service for evaluation and management of your peri-hepatic fluid collection.
* Please take any new medications as prescribed.
* Please take the prescribed analgesic medications as needed.
You may not drive or operate heavy machinery while taking narcotic analgesic medications.
Provider: [**Name10 (NameIs) 1571**] FUNCTION LAB Phone:[**Telephone/Fax (1) 609**] Date/Time:[**2136-8-17**] 11:40  Provider: [**Name10 (NameIs) 1570**],INTERPRET W/LAB NO CHECK-IN [**Name10 (NameIs) 1570**] INTEPRETATION BILLING Date/Time:[**2136-8-17**] 12:00  Provider: [**Name10 (NameIs) **] [**Name8 (MD) 611**], M.D.
